U.S. regulators OK first new Alzheimer’s drug in nearly 20 years, against the advice of their own outside experts

WASHINGTON (AP) — U.S. regulators OK first new Alzheimer’s drug in nearly 20 years, against the advice of their own outside experts.

Copyright © 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up